{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:54:03Z","timestamp":1767146043577,"version":"build-2238731810"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T18:46:20Z","timestamp":1541789180000},"page":"590-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glycemic and lipids control in patients with diabetes and cardiovascular or renal diseases across all the government health sectors in the Emirate of Dubai, United Arab Emirates"],"prefix":"10.1016","volume":"13","author":[{"given":"Fauzia","family":"Rashid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elamin","family":"Abdelgadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Alsaeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Budoor","family":"Alemadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad H.","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatheya","family":"Alawadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaaeldin","family":"Bashier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2018.11.013_bib3","article-title":"Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates","volume":"5","author":"Jelinek","year":"2017","journal-title":"BMJ Specialist Journals: BMJ Open Diabetes Res Care"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.diabres.2007.04.008","article-title":"Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates","volume":"78","author":"Saadi","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.dsx.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the american diabetes association (ADA) and the european association for the study of diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.11.013_bib6","series-title":"Diabetes Care","article-title":"6. Glycemic targets: standards of medical care in diabetes-2018","author":"American Diabetes Association AD","year":"2018"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.diabres.2005.03.024","article-title":"Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)","volume":"70","author":"Harris","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-018-0661-8","article-title":"Group for the D study. Individualised treatment targets in patients with type-2 diabetes and hypertension","volume":"17","author":"Schmieder","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"15","key":"10.1016\/j.dsx.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2018.11.013_bib10","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications research group","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2018.11.013_bib11","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-1278","article-title":"Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial","author":"Riddle","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.11.013_bib12","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","author":"ADVANCE Collaborative Group","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2018.11.013_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","author":"Duckworth","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2018.11.013_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-015-0020-7","article-title":"Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry","author":"Schmieder","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.dsx.2018.11.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2004.07.003","article-title":"Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study","author":"Comaschi","year":"2005","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.dsx.2018.11.013_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S1575-0922(09)71406-8","article-title":"Estudio epidemiol\u00f3gico del perfil cl\u00ednico y control gluc\u00e9mico del paciente diab\u00e9tico atendido en centros de atenci\u00f3n primaria en Espa\u00f1a (estudio EPIDIAP)","author":"de Pablos Velasco","year":"2009","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.dsx.2018.11.013_bib17","article-title":"Do we achieve the targets for diabetic patients; deep looks to primary care practice","author":"Qurashi","year":"2014","journal-title":"J\u00a0Gen Pract"},{"key":"10.1016\/j.dsx.2018.11.013_bib18","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12902-016-0090-1","article-title":"Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain","volume":"16","author":"Mi\u00f1ambres","year":"2016","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.dsx.2018.11.013_bib20","doi-asserted-by":"crossref","unstructured":"Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et\u00a0al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 9(2):129\u2013169.","DOI":"10.1016\/j.jacl.2015.02.003"},{"issue":"5","key":"10.1016\/j.dsx.2018.11.013_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5551\/jat.31179","article-title":"Suboptimal control of lipid levels: results from 29 countries participating in the centralized Pan-regional surveys on the undertreatment of hypercholesterolaemia (CEPHEUS)","volume":"23","author":"Chiang","year":"2016","journal-title":"J\u00a0Atherosclerosis Thromb"},{"key":"10.1016\/j.dsx.2018.11.013_bib22","doi-asserted-by":"crossref","DOI":"10.1185\/03007995.2014.965774","article-title":"Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf","author":"Al-Rasadi","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.013_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/1570161115666170705153815","article-title":"The management of dyslipidaemia in patients with type 2 diabetes mellitus receiving lipid-lowering drugs: a sub-analysis of the CEPHEUS findings","volume":"16","author":"Shehab","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.013_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","article-title":"Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes","volume":"291","author":"Saydah","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.dsx.2018.11.013_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1559-4564.2006.05910.x","article-title":"Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002","volume":"1","author":"Ong","year":"2006","journal-title":"J\u00a0Cardiometab Syndr"},{"key":"10.1016\/j.dsx.2018.11.013_bib26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1874192401206010126","article-title":"A\u00a0clinical audit on diabetes care in patients with type 2 diabetes in Al-ain, United arab emirates","volume":"6","author":"Shehab","year":"2012","journal-title":"Open Cardiovasc Med J"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.013_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/2230-8210.113751","article-title":"Glycemic variability: Clinical implications","volume":"17","author":"Satya Krishna","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.013_bib28","article-title":"Clinical diabetes care of patients with type 2 diabetes at a major tertiary care hospital in the United Arab Emirates","volume":"2","author":"Ali Malik","year":"2015","journal-title":"J\u00a0Diabetes, Metab Disord Control"}],"updated-by":[{"DOI":"10.1016\/j.dsx.2020.12.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187140211830451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187140211830451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T18:48:40Z","timestamp":1547146120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187140211830451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S187140211830451X"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.013","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycemic and lipids control in patients with diabetes and cardiovascular or renal diseases across all the government health sectors in the Emirate of Dubai, United Arab Emirates","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}